MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Detection of α-synuclein seeds in skin samples from PPMI participants

    Y. Ma, C. Farris, R. Johnson, S. Rosete-Gonzalez, D. Murphy, T. Foroud, L. Concha (San Diego, USA)

    Objective: To evaluate the presence of α-synuclein seeds (syn-seeds) in skin samples from PPMI participants, including prodromal, early and late Parkinson’s disease (PD) using a…
  • 2026 International Congress

    Long-Term Efficacy and Determinants of Motor and Quality-of-Life Outcomes Following Bilateral GPi-DBS in Dystonia

    G. Yılmaz çakan, B. Arı, N. Helvacı Yılmaz, Y. Samancı, G. Kenangil, A. Zırh (Istanbul, Turkey)

    Objective: The present study aimed to evaluate the clinical features and clinical outcomes in dystonia patients who underwent bilateral deep brain stimulation of the globus…
  • 2026 International Congress

    Quantitative susceptibility mapping with 7T MRI as a novel imaging biomarker for periventricular degeneration in normal pressure hydrocephalus: A pilot study

    S. Kim, M. Kweon, H. Chang, J. Heo, S. Oh, S. Tak, E. Oh (Jecheon, Chungcheongbuk-do, Republic of Korea)

    Objective: We try to investigate periventricular susceptibility alterations using QSM to establish a novel, accurate early imaging biomarker for NPH. Background: Normal pressure hydrocephalus (NPH)…
  • 2026 International Congress

    Revisiting Prodromal Diagnostic Criteria in MSA: The Need for Early MRI-Based Diagnosis

    J. Ahn, W. Kim, J. Youn, JH. Cho (Seoul, Republic of Korea)

    Objective: This prospective cohort study investigated the role of neuroimaging for the early and accurate identification of multiple system atrophy (MSA) in patients with indeterminate…
  • 2026 International Congress

    Data-driven Trajectories of Atrophy Explain Clinical Heterogeneity Across Lewy Body Diseases

    A. Konuri, G. Leal, T. Transcend Consortium, G. Halliday, S. Lewis, R. Weil, R. Landin-Romero, C. Lambert, N. Oxtoby, E. Matar (Sydney, Australia)

    Objective: To identify data-driven spatiotemporal trajectories of brain atrophy across the Lewy body disease spectrum and establish their relationship to clinical heterogeneity, core symptom profiles,…
  • 2026 International Congress

    Phase 2 Trial for the Treatment of Early-stage Parkinson’s Disease with TJ0113, a Small Molecule Mitophagy Activator

    W. Luo, ZD. Cen, XF. Cen, XH. Chen, S. Wu, Y. Tan, LQ. Mao, XL. Mao, B. Zhang, W. Lv, SZ. Liu, YP. Wang, D. Liu, HG. Xia (Zhejiang, China)

    Objective: To investigate the efficacy and safety of TJ0113 for patients with early-stage Parkinson's disease. Background: Mitochondrial dysfunction, particularly decreased mitophagy, may contribute to the pathogenesis of…
  • 2026 International Congress

    Digital acoustic assessment of alleviating maneuvers in laryngeal dystonia: a 2-patient case series

    I. Khasanov, D. Khasanova (Kazan, Russian Federation)

    Objective: To assess whether digital acoustic analysis can objectively capture posture-dependent symptom modulation in laryngeal dystonia. Background: Objective tools for quantifying alleviating maneuvers in laryngeal…
  • 2026 International Congress

    Standardised Home-Based Walk Tests Can Capture Gait Differences in Parkinson’s Disease Using Wearable Sensors

    C. Sotirakis, N. Conway, J. Ren, M. Dockendorf, O. Patil, S. Lee, J. Fitzgerald, C. Antoniades (University of Oxford, United Kingdom)

    Objective: To evaluate the feasibility and discriminative utility of a standardised home-based walk test using wearable sensors in people with Parkinson's disease (PwP). Background: Wearable…
  • 2026 International Congress

    Handwriting in PRKN-PD: A Study of Movement Control

    A. Gallagher, C. Fearon, T. Lynch (Dublin, Ireland)

    Objective: To explore differences in movement control between PRKN-PD and gene-negative YOPD patients using a structured handwriting task. Background: Idiopathic Parkinson’s disease (IPD) symptoms are…
  • 2026 International Congress

    Development and initial feasibility of a Randomised Pilot Trial of Enhanced Tai Chi for Parkinson’s Disease

    M. Qamar, O. Awogbemila, R. Savla, L. Batzu, S. Rota, A. Hernandez Pena, C. Yang, M. Freris, B. Dikong, J. Whitney (London, United Kingdom)

    Objective: To describe the design and feasibility of a randomised controlled pilot study evaluating an Enhanced Tai Chi intervention for people with Parkinson’s disease (NCT07297368).…
  • « Previous Page
  • 1
  • …
  • 123
  • 124
  • 125
  • 126
  • 127
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley